Literature DB >> 11880715

The role of surgery for patients with metastatic melanoma.

Peter J Allen1, Daniel G Coit.   

Abstract

When deciding to perform a resection for metastatic melanoma one should first decide whether the intent of the procedure is curative or palliative. When the resection is palliative, the success of surgical treatment will depend on the presence of identifiable symptoms, the morbidity of the procedure, the course of the disease, and the ability to communicate the treatment goals among surgeon, patient, and family. When the resection is curative, survival will depend on the ability of the surgeon to select patients with a pattern of recurrence suggestive of less aggressive tumor biology. Factors generally found predictive of improved survival, and therefore reflective of tumor biology, include longer disease-free interval, fewer numbers of metastases, and the ability to obtain a complete resection. Resection of metastases in patients who recur within one-year, who present with multiple lesions, and who present with disease that cannot be completely resected, will not result in long-term survival.

Entities:  

Mesh:

Year:  2002        PMID: 11880715     DOI: 10.1097/00001622-200203000-00014

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  9 in total

1.  Breast metastases as the first sign of recurrence of a cutaneous melanoma.

Authors:  Teresa Sampedro Gimeno; Fernando Moreno Antón; Sara López-Tarruella Cobo; José Luis González Larriba; Vicente Furio Bacete; Eduardo Díaz-Rubio García
Journal:  Clin Transl Oncol       Date:  2006-01       Impact factor: 3.405

2.  The Surgeons' Role When Systemic Therapies Fail in Metastatic Melanoma: The Salvage Metastasectomy.

Authors:  Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2021-07-21       Impact factor: 5.344

Review 3.  Optimal management of metastatic melanoma: current strategies and future directions.

Authors:  Marta Batus; Salman Waheed; Carl Ruby; Lindsay Petersen; Steven D Bines; Howard L Kaufman
Journal:  Am J Clin Dermatol       Date:  2013-06       Impact factor: 7.403

4.  Surgical management of intraabdominal metastases from melanoma: role of the neutrophil to lymphocyte ratio as a potential prognostic factor.

Authors:  Ferdinando C M Cananzi; Angus Dalgleish; Satvinder Mudan
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

5.  Short length of stay and rapid recovery to normal function after surgery for metastatic melanoma to abdominal and retroperitoneal viscera.

Authors:  Lynn T Dengel; Craig L Slingluff
Journal:  J Surg Oncol       Date:  2009-11-01       Impact factor: 3.454

6.  Intraoperative application of fibrin sealant does not reduce the duration of closed suction drainage following radical axillary lymph node dissection in melanoma patients: a prospective randomized trial in 58 patients.

Authors:  Heiko Neuss; Wieland Raue; Gerold Koplin; Wolfgang Schwenk; Christian Reetz; Julian W Mall
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

7.  Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients.

Authors:  Francesca Tauceri; Gianni Mura; Mauro Roseano; Massimo Framarini; Laura Ridolfi; Giorgio M Verdecchia
Journal:  Langenbecks Arch Surg       Date:  2008-03-04       Impact factor: 3.445

8.  Chance mechanisms affecting the burden of metastases.

Authors:  Wayne S Kendal
Journal:  BMC Cancer       Date:  2005-10-26       Impact factor: 4.430

9.  Metastatic malignant melanoma causing ileo-ileal intussusception.

Authors:  D Yerrakalva; R Ackroyd; F Lee
Journal:  J Surg Case Rep       Date:  2011-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.